Natalia Borinshteyn, MD, PhDVice President HCV Launch team; Medical Affairs
Greater New York City Area
Vice President HCV Launch team; Medical Affairs
Member
Member
TA Lead Immunology/GI, US & Global Medical Affairs
Head of Portfolio Strategy Novel Prevention & Cure approaches, Global Diabetes Division
Senior Director, Head of New Business Opportunities for Diabetes Prevention and Complications
Senior Director New Products Phase I-IIB, CV/Metabolism/Dermatology
Sculptra Medical/Training Director
Senior Product Manager, Rimonabant
Senior Product Manager Lantus
Senior Group Product Manager, Allegra, OTC etc
Product Manager, Maalox and Essentiale
Harvard Business School
University of Pennsylvania - The Wharton School
University of Pennsylvania - The Wharton School
Scientific Institute of Pediatrics
Российский Государственный Медицинский Университет (РГМУ)
Recommendations: 10
Diabetes
Pharmaceutical Sales
Pharmaceutical Industry
Clinical Development
Dermatology
Clinical Trials
Endocrinology
Product Launch